Last Close Price 26.49USD Average target price 31.18USD Spread / Average Target +17.69% Consensus Profit revisions Estimate revisions Created with Highcharts 9.3.3TechnologyTechnologyConsumerCyclicalsConsumerCyclicals Consumer …
The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York....
在研机构 Pfizer Australia Pty Ltd.Pfizer Japan, Inc.Pharmacia & Upjohn LLC 非在研机构 Pfizer Inc. 最高研发阶段批准上市 首次获批日期 日本(1991-01-18), 特纳综合症 最高研发阶段(中国)- 特殊审评孤儿药 (美国) 登录后查看时间轴 结构/序列 Sequence Code 26401985 当前序列信息引自: *** 关联 ...
Based on19Wall Street analysts offering 12 month price targets forPfizerin the last3 months. The average price target is$31.56with a high forecast of$45.00and a low forecast of$25.00. The average price target represents a24.99%change from the last price of$25.25. ...
(USA)Inc.and Zydus Lifesciences Ltd.;and in December 2022,the same entities filed a 260、 patent-infringement suit in theU.S.District Court for the District of New Jersey against Sun in connection with those companies respective ANDAs seeking approval to market genericversions of enzalutamide....
AGF Management Ltd. now owns 1,223,841 shares of the biopharmaceutical company’s stock valued at $34,243,000 after acquiring an additional 76,464 shares during the last quarter. Finally, HHM Wealth Advisors LLC raised its stake in shares of Pfizer by 9.3% during the second quarter. HHM...
•the decrease in the value of the portfolio performance share grants reflecting changes in the price of Pfizer's common stock, as well as management's assessment of the probability that the specified performance criteria will be achieved; ...
CStone Pharmaceuticals (“CStone”, HKEX: 2616)] and Pfizer Investment Co. Ltd. ("Pfizer Investment") and Pfizer Corporation Hong Kong Limited ("Pfizer Hong Kong") (both of which are subsidiaries of Pfizer Inc. (NYSE: PFE)) announced today the formation of a strategic collaboration that enco...
Saunders already is focused on closing Allergan's $40.5 billion deal to sell its generic drug business to Israel's Teva Pharmacueticals Industries Ltd., the world's top generic drugmaker. He expects that to close by the end of June, bringing Allergan about $36 billion after taxes to inves...
(P/CF) ratio. Companies likeTyson Foods, Inc.,AXIS Capital Holdings Ltd.,Pfizer Inc.andGeneral Motors Co.boast a low P/CF ratio. The P/CF ratio evaluates the market price of a stock relative to the amount of cash flow that the company is generating on a per-share basis — ...